Know and Own Your Movement-related Metrics Via Wearable Devices

Launched by THE UNIVERSITY OF TEXAS AT ARLINGTON · Aug 3, 2022

Keywords

ClinConnect Summary

This clinical trial, titled "Know and Own Your Movement-related Metrics Via Wearable Devices," is designed to help cancer survivors who are at high risk for type 2 diabetes (T2D) become more active. T2D is a common health issue that can make recovery from cancer more challenging, especially for those who don’t exercise enough. The study will use wearable devices to track daily activity and a continuous glucose monitor to show how exercise affects their blood sugar levels in real-time. The goal is to encourage survivors to see the benefits of physical activity on their health, motivating them to stay active.

To be eligible for this trial, participants must be at least 18 years old, have had a cancer diagnosis, and completed their main treatment at least 3 months ago. They should also be at high risk for T2D but not currently diagnosed with diabetes, and they need to be able to participate in moderate exercise. Participants will use a smartphone to access the study’s apps and will receive personalized feedback on their activity levels and health metrics. This study is a unique opportunity to learn how technology can help cancer survivors improve their health through exercise.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • be 18 years or older
• • have had a diagnosis of cancer
• • have completed curative-intended treatment for at least 3 months (except hormone therapy or long-term maintenance chemotherapy)
• • be at high-risk for type 2 diabetes based on the American Diabetes Association Type 2 Diabetes Risk Test
• • currently insufficiently active
• • capable of participating in moderate-vigorous intensity unsupervised exercise
• • have no current diagnosis or history of type 1 or 2 diabetes
• • able to speak, read, and write in English
• • have a smartphone with daily internet access
• Exclusion Criteria:
• • currently taking oral antidiabetic agents (OADs)
• • current treatment with any insulin regimen other than basal insulin, e.g. prandial or pre-mixed insulin
• • currently pregnant
• • on dialysis
• • have self-reported health issues that limit physical activity
• • work overnight shifts
• • unwilling to use the study devices
• • current participation in other exercise or weight loss-related program or intervention
• • currently on a low-carb diet
• • current use of other implanted medical devices such as pacemakers
• • do not have a smartphone that is compatible with the Fitbit and the LibreLink apps